Rapid Confirmation of the Zaire Ebola Virus in the Outbreak of the Equateur Province in the Democratic Republic of Congo: Implications for Public Health Interventions

Clinical Infectious Diseases

Volumn 68, Issue 2, 2019, Pages 330-333

  Mbala Kingebeni, Placide ^a,b   Villabona Arenas, Christian Julian ^b   Vidal, Nicole ^b   Likofata, Jacques ^c   Nsio Mbeta, Justus ^d   Makiala Mandanda, Sheila ^a   Mukadi, Daniel ^a   Mukadi, Patrick ^a   Kumakamba, Charles ^a,e   Djokolo, Bathe ^d   Ayouba, Ahidjo ^b   Delaporte, Eric ^b   Peeters, Martine ^b   Muyembe Tamfum, Jean Jacques ^a   Ahuka Mundeke, Steve ^a  

^a Clinique Universitaire de Kinshasa   (Congo)

^b UNIV MONTPELLIER   (France)

^c Laboratoire Provinciale   (France)

^d Direction Générale de Lutte Contre la Maladie   (France)

^e METABIOTA INC   (United States)

Author keywords

Democratic Republic of Congo; Ebola; Nanopore sequencing

Indexed keywords

ARTICLE; CONTROLLED STUDY; DEMOCRATIC REPUBLIC CONGO; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; GENE AMPLIFICATION; HUMAN; LABORATORY TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUBLIC HEALTH; VIRUS DETECTION; CLASSIFICATION; EBOLAVIRUS; GENETICS; IMMUNOLOGY; PHYLOGENY;

EBOLA VACCINE;

DEMOCRATIC REPUBLIC OF THE CONGO; DISEASE OUTBREAKS; EBOLA VACCINES; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; PHYLOGENY;

EID: 85051410964     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciy527     Document Type: Article

References (9)

1. World Health Organization (WHO). Ebola virus disease, Democratic republic of Congo. External situation report update report 8. Available at: http://apps. who. int/iris/bitstream/handle/10665/272761/SITREP-EVD-DRC-20180605-eng. pdf?ua=1. Accessed 12 June 2018.
2. World Health Organization (WHO). Meeting of the Strategic Advisory Group of Experts on immunization-conclusions and recommendations. Ebola vaccines. Available at: http://www. who. int/csr/resources/publications/ebola/sage-ebola-vaccination. pdf?ua=1. Accessed 12 June 2018.
3. Henao-Restrepo AM, Longini IM, Egger M, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015; 386:857-66.
4. Gsell PS, Camacho A, Kucharski AJ, et al. Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report. Lancet Infect Dis 2017; 17:1276-84.
5. Kuhn JH, Andersen KG, Baize S, et al. Nomenclature-and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses 2014; 6:4760-99.
6. Pigott DM, Millear AI, Earl L, et al. Updates to the zoonotic niche map of Ebola virus disease in Africa. Elife 2016; 5. pii:e16412.
7. He B, Feng Y, Zhang H, et al. Filovirus RNA in fruit bats, China. Emerg Infect Dis 2015; 21:1675-7.
8. Quick J, Loman NJ, Duraffour S, et al. Real-time, portable genome sequencing for Ebola surveillance. Nature 2016; 530:228-32.
9. Hoenen T, Groseth A, Rosenke K, et al. Nanopore sequencing as a rapidly deployable Ebola outbreak tool. Emerg Infect Dis 2016; 22:331-4.